The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
PRME · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
NUVB · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
GLUE · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
SMMT · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | PRME | NUVB | GLUE | SMMT |
|---|---|---|---|---|
| Moat Score (0–100) | 37 (highest) | 37 (highest) | 37 (highest) | 37 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 70 (highest) | 70 (highest) | 70 (highest) | 20 |
| Pricing power | — | — | — | — |
| Returns on capital | 0 | 0 | 0 | 7 (highest) |
| Balance-sheet safety | 55 | 55 | 55 | 78 (highest) |
| Capital discipline | 24 | 24 | 24 | 44 (highest) |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $546M | $2.2B | $1.5B | $11.8B |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |